Corcept Therapeutics (NASDAQ:CORT) is my favorite type of biotech company. It has an approved, marketed product with ramping sales, promising pipeline candidates, and is beginning to turn a profit. Both guidance by the company and analyst coverage suggest substantial growth in earnings and revenue. While not without the inherent risks of investing in a small/mid-cap biotech companies,....More>>>
I’ve made a career in spotting trillion-dollar themes in the market, first as an equity analyst and more recently as a pre-IPO investor.
Any analyst can create a cash flow model — it’s as simple as working through a company’s financial statements to scrutinize the true cash-generating power of the investment. Every broker, research firm and fund manager has....More>>>
Semiconductor company Broadcom (NASDAQ:AVGO) reported its fiscal first-quarter results after the market close on March 1. Revenue soared compared to the first quarter of 2016 thanks to the Broadcom-Avago merger, but sequential revenue growth was weighed down by sluggishness in the wired infrastructure and wireless communications segments. Here’s what investors need to know about Broadcom’s....More>>>
Related TRST Earnings Scheduled For October 21, 2016 Major Accounting Changes Are Coming To The Financial Industry Related MORN One Of The World's Most Powerful Women, Fidelity Personal Investing President Kathleen Murphy, To Tell Her Story At The Benzinga....More>>>
The recent announcement that Pilgrim’s Pride (NYSE:PPC) will be acquiring GNP Company is a welcome reprieve to those of us that see the value in the company. As investors likely already know, accusations of price index manipulation of the Georgia Dock index continue to swirl in the media, and the interest from the press doesn’t seem to be waning. Why should it? It has all the trappings....More>>>
Employing contrarian investing tactics is exceptionally difficult. Evolutionarily speaking, we are inclined to follow the majority and not stray from the pack. However, in investing, it can be extraordinarily lucrative to deviate from the consensus. The consensus view of Bed Bath & Beyond (NASDAQ:BBBY) is that the company faces several headwinds that will stagnate growth and cause the stock....More>>>
In 2011 Scott’s Investments began tracking a momentum portfolio which ranks a basket of ETFs based on price momentum and volatility. In 2014 I also introduced a pure momentum system, which ranks the same basket of ETFs based solely on 6 month price momentum. The first portfolio was previously called the “ETFReplay.com Portfolio” but at the beginning of 2016 was renamed “Conservative....More>>>
On Monday, our Under the Radar Moversnewsletter suggested shorting women’s health stock Juniper Pharmaceuticals (NASDAQ: JNP):
Juniper Pharmaceuticals shares have yet to break under a key support level at $5.00. But, waiting until that happens may be too late. After some continued testing of that floor, if-and-when the support should break, the ensuing selloff could materialize in a....More>>>
Singapore's largest property developer, CapitaLand (OTCPK:CLLDY) (CATL.SI) had a pretty good 2017. Helped by improving conditions in Singapore and China, not to mention significant project openings, CapitaLand's local shares climbed 20% and the ADRs did even better.
A power outage hit the CES consumer electronics show in Las Vegas, dimming the lights in one of the main convention halls hosting demonstrations from the likes of LG Electronics Inc. and Samsung Electronics Co.
“There is an isolated power outage at the Las Vegas Convention Center. W
In Lahore and Karachi, American flags were burned in front of TV cameras after President Trump’s decision on Jan. 4 to withhold $2 billion of security aid from Pakistan to punish it for allegedly harboring terrorists. The country’s government issued angry statements claiming no ins